CA17129 – Catalysing transcriptomics research in cardiovascular disease
CardioRNA COST Action CA17129 is a collaborative pan-European network of multidisciplinary researchers, clinicians, and industrial partners aiming to accelerate the understanding of transcriptomics in cardiovascular disease (CVD) and further the translation of experimental data into usable applications to improve personalized medicine in this field.
WG1 Review out now in Basic Research in CardiologyMay 6, 2023
We are happy to share our review on integrating epigenetic and other omics data sets to elevate our knowledge of complex diseases, such as cardiovascular disease. Out now in Basic Research in Cardiology. https://link.springer.com/article/10.1007/s00395-023-00986-3 A team effort from members of the CardioRNA and AtheroNET COST Actions.
New article on soft skills for early career researchers, lead by EU-CardioRNA traineesApril 18, 2023
Check out this insightful new article lead by EU-CardioRNA trainees and initiated at the training school held in Crete in April 2022! The science behind soft skills: Do’s and Don’ts for early career researchers and beyond. A review paper from the EU-CardioRNA COST Action CA17129 Available now from Open Research Europe The science behind soft […]
Final EU-CardioRNA MC & WG meeting, Nicosia 22-24 February 2023March 4, 2023
February 22nd – 24th 2023 saw the 9th and MC & WG final meeting of the EU-CardioRNA COST Action held at the University of Nicosia, hosted by Kyriacos Felekkis and Christos Papaneophytou. 66 CardioRNA members and partners from 16 countries attended, with over a third of attendees being YRIs (Young Researchers and Innovators). The packed […]